lung cancer Archive — Page 5 of 16
-
November 12, 2020
New therapeutic target for lung cancer
Vanderbilt researchers have identified a new molecular partner — and potential therapeutic target — in a signaling axis that drives lung cancer. -
September 23, 2020
Journal Watch
-
September 23, 2020
Tailored Treatments
-
September 23, 2020
Unraveling a Viral Maze
-
August 13, 2020
Newer targeted therapy prolongs life for lung cancer patients
Patients with ALK-positive non-small cell lung cancer treated with ensartinib fared better and lived longer than those who received crizotinib, according to results of a phase 3 study. -
July 30, 2020
Iams honored by National Comprehensive Cancer Network
Wade Iams, MD, MSCI, assistant professor of Medicine, is the recipient of a National Comprehensive Cancer Network Foundation Young Investigator Award. -
July 23, 2020
Criteria for lung cancer screens may be expanded
The U.S. Preventive Services Task Force (USPSTF) is recommending two changes that will nearly double the number of people eligible for lung cancer screening by lowering the age from 55 to 50 and reducing the number of smoking history pack years from 30 to 20.